Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: '584 revisited, please note final quotation:Milestone

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

'584 revisited, please note final quotation:

milestone

Feb 15, 2009 12:32PM

Re: '584 revisited, please note final quotation:

Cautious

Feb 15, 2009 06:57PM

Re: '584 revisited, please note final quotation: Cautious

milestone

Feb 16, 2009 03:08AM

Re: '584 revisited, please note final quotation/Milestone

dys1

Feb 16, 2009 04:00AM

srandl

Rank: Vice President [?]

Points: 5514 [?]

Votes: 79 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: '584 revisited, please note final quotation:Milestone

in response to

'584 revisited, please note final quotation:

milestone

posted on Feb 16, 2009 06:42AM

Nice post! This is what I was understanding as well from what I've been reading is that the 584 invention is all on a Microprocessor or on a micro scale if you will, where as the sited prior art is on a Macro scale using main frame architecture. Moore has to be pulling his hair out talking to these USPTO examiners.

All the best,

Steve

3 Recommendations

Re: '584 revisited, please note final quotation:Cautious

srandl

Feb 16, 2009 06:56AM

Re: '584 revisited, please note final quotation/Milestone

optymystic

Feb 16, 2009 07:23AM

Re: '584 revisited, please note final quotation: Cautious

Cautious

Feb 16, 2009 07:33AM